Russian pharmaceutical market to reach 3.7 trillion roubles by 2030

The Russian government is considering designing additional measures aimed at creating conditions for the growth of domestic pharmaceutical market during the period of 2024-2025, reports The Pharma Letter’s local correspondent.

In 2023, the market amounted to 2.3 trillion roubles ($24.1 billion) in value terms, while over the last four years it has grown by 60.1%. The share of Russian drugs in the overall structure of the market reached 36.8% compared to 30.8% in 2019 in value terms and more than 60% in terms of volume.

As part of the latest state plans, the market should reach 3.7 trillion roubles ($39.6 billion) in value term by 2030, while the share of drugs produced in Russia in a full cycle basis, including active ingredients should reach 80%.